Tnkase
Payments companies reported to CMS as associated with Tnkase. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tnkase, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tnkase
These are the largest totals companies reported as associated with Tnkase. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Liebeskind | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $65,700.00 |
| Sarah Lee | Stanford, CA | Vascular Neurology | $28,980.00 |
| Christopher Streib | Minneapolis, MN | Neurology (Psychiatry & Neurology) | $5,650.00 |
| Michael Marks | Stanford, CA | Neuroradiology | $3,620.00 |
| Amrou Sarraj | Houston, TX | Vascular Neurology | $3,620.00 |
| Jeffrey Saver | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $2,240.00 |
| Scott Kasner | Philadelphia, PA | Vascular Neurology | $1,839.55 |
| Tudor Jovin | Pennington, NJ | Neurocritical Care | $1,820.00 |
| Arthur Pancioli | Cincinnati, OH | Emergency Medicine | $1,590.00 |
| Ameer Hassan | Harlingen, TX | Vascular Neurology | $239.10 |
Prescribed Tnkase?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.